Dishman Carbogen Amcis Limited announced on 5 May 2026 that its wholly-owned subsidiary, CARBOGEN AMCIS (Shanghai) Co. Ltd., has successfully completed an unannounced Good Manufacturing Practice (GMP) inspection by China's National Medical Products Administration (NMPA) at its Shanghai facility. The disclosure was made under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015.

Inspection Overview

The unannounced inspection was conducted on 14 April 2026 and encompassed a comprehensive on-site assessment of the Shanghai facility's operations. Key details of the inspection are summarised below:

The inspection covered the following areas:

• API manufacturing processes and operations
• Quality control laboratories
• Documentation practices
• Overall quality management systems
• Site's Quality System readiness

The inspection concluded without observations, and no issues requiring formal explanation were identified. Recommendations were provided to support ongoing continuous improvement.

Leadership Remarks

Senior officials from CARBOGEN AMCIS commented on the significance of the outcome.

Stephanie Schlienger, V.P. Quality & Compliance of CARBOGEN AMCIS, stated: "This outcome reflects the high level of preparedness and expertise demonstrated by our Shanghai team, as well as the strength and maturity of our Quality System. The successful completion of an unannounced inspection with no observations underlines our commitment to maintaining the highest GMP standards across all aspects of our operations."

Simone Maggi, Site Quality Head of CARBOGEN AMCIS Shanghai, noted: "For the Shanghai site, the significance of this inspection lies in the fact that it was unannounced. Such inspections test the system as it operates in routine conditions, and this result confirms both the consistency of GMP execution across the site and the readiness and competence of our team."

Stephan Fritschi, CEO of CARBOGEN AMCIS, added: "Successfully completing an unannounced NMPA inspection with no observations is a significant achievement and a strong validation of our global quality culture. It demonstrates our ability to consistently meet rigorous regulatory expectations and reinforces confidence in our Shanghai site as a reliable partner for our customers worldwide."

Role of the Shanghai Facility

The Shanghai facility plays a key role within CARBOGEN AMCIS' global network, supporting API manufacturing and process development activities. The site's successful inspection outcome acknowledges its capability to deliver high-quality services in line with international regulatory requirements. CARBOGEN AMCIS is a leading service provider offering drug development and commercialization services to the pharmaceutical and biopharmaceutical industries across all stages of clinical development and product life cycle. Dishman Carbogen Amcis Limited, headquartered in Ahmedabad, India, is a global outsourcing partner for the pharmaceutical industry, with operations across Europe, China, and India.

Dishman Carbogen Amcis Limited has submitted its quarterly compliance certificate to stock exchanges, fulfilling regulatory requirements under SEBI (Depositories and Participants) Regulations, 2018. The pharmaceutical company filed the confirmation certificate for the quarter ended March 31, 2026, demonstrating its commitment to regulatory compliance.

Regulatory Compliance Submission

The company submitted the certificate on April 13, 2026, to both BSE Limited and National Stock Exchange of India Limited. The submission was made by Company Secretary Shrima Dave, who communicated with the respective listing departments of both exchanges.

Certificate Confirmation by RTA

MUFG Intime India Private Limited, formerly known as Link Intime India Private Limited, served as the Registrar and Share Transfer Agent (RTA) for this compliance process. The RTA issued the confirmation certificate on April 1, 2026, validating the company's adherence to dematerialisation requirements.

Key Confirmations Made

The RTA confirmed several critical aspects of securities handling during the quarter:

• Securities received from depository participants for dematerialisation were properly confirmed to depositories
• All securities comprised in certificates have been listed on stock exchanges where earlier issued securities are listed
• Security certificates received for dematerialisation were confirmed or rejected within prescribed timelines
• Received certificates were mutilated and cancelled after due verification by depository participants
• Depository names were substituted in the register of members as registered owners

Corporate Information

Dishman Carbogen Amcis Limited operates from its corporate house located on Iscon-Bopal Road, Ambli, Ahmedabad. The company maintains its registered operations in Ahmedabad, with pincode 380058.

The certificate was signed by Ashok Shetty, Sr. Vice President-Corporate Registry at MUFG Intime India Private Limited, ensuring proper authorization and validation of the compliance documentation. This quarterly submission reflects the company's ongoing commitment to maintaining transparency and regulatory adherence in its securities operations.